More Immutep Ltd news Immutep LtdASX: IMM Lead-in phase completed for ph2/3 trial in Breast Cancer Nov 6, 2023 at 2:49 AM UTC · Issued by Immutep Ltd As issuedPlain English Immutep Ltd has released a press release. View Attachment
